Psychedelics Filament Health undertakes innovative clinical trial FDA-approved psilocin study in California said to be first of its kind for industry Rowan DunneJuly 11, 2022
Psychedelics U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report As rates of mental health disorders increase the demand for psychedelic treatments do too Rowan DunneJune 6, 2022
Canada Canadian government to grant $3M for psilocybin research studies The aim is to expand the evidence base on psilocybin-assisted psychotherapy to inform practical policies and regulations Natalia Buendia CalvilloMay 5, 2022